BRCA1 and neoplasm: BRCA1‐deficient cells, for instance, exhibit SL with inhibition of NAD+‐metabolising enzymes such as NAMPT and NMNAT1/2, indicating that tumours may evade PARPi by remodelling NAD+ metabolism.106